Related content

XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis

By Economopoulos Konstantinos  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 439-443

Springer Publishing Company

Access to resources Recommend Favorite

XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis

By Yan Yulan   Liang Hongjie   Li Ruolin   Xie Li   Li Meng   Li Shan   Qin Xue  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2711-2715

Springer Publishing Company

Access to resources Recommend Favorite

Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis

By Liu Jun   Zhou Zheng   Lai Ting   Yin Jinbo  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1083-1087

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

By Wei Shu-zhen  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 315-321

Humana Press, Inc

Access to resources Recommend Favorite

Genetic polymorphism of XRCC3 Thr²⁴¹Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies

By Lee Sang-Ah   Lee Kyoung-Mu   Park Sue   Choi Ji-Yeob   Kim Bongcheol   Nam Jinwu   Yoo Keun-Young   Noh Dong-Young   Ahn Sei-Hyun   Kang Daehee  

Breast Cancer Research and Treatment, Vol. 103, Iss. 1, 2007-05 ,pp. : 71-76

Springer Publishing Company

Access to resources Recommend Favorite